Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice

Hdl Handle:
http://hdl.handle.net/10147/237750
Title:
Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice
Authors:
Zagozdzon, Agnieszka M; O’Leary, Patrick; Callanan, John J; Crown, John; Gallagher, William M; Zagozdzon, Radoslaw
Citation:
BMC Cancer. 2012 May 30;12(1):209
Issue Date:
30-May-2012
URI:
http://dx.doi.org/10.1186/1471-2407-12-209; http://hdl.handle.net/10147/237750
Abstract:
AbstractBackgroundNumerous transgenic models have been generated to study breast cancer. However, despite many advantages, traditional transgenic models for breast cancer are also burdened with difficulties in early detection and longitudinal observation of transgene-induced tumours, which in most cases are randomly located and occur at various time points. Methods such as palpation followed by mechanical measurement of the tumours are of limited value in transgenic models. There is a crucial need for making these previously generated models suitable for modern methods of tumour visualisation and monitoring, e.g. by bioluminescence-based techniques. This approach was successfully used in the current study.ResultsA new mouse strain (MMTV-Luc2 mice) expressing Luc2 luciferase primarily in mammary tissue in females, with low-level background expression in internal organs, was generated and bred to homozygosity. After these mice were intercrossed with MMTV-PyVT mice, all double transgenic females developed mammary tumours by the age of 10 weeks, the localisation and progression of which could be effectively monitored using the luminescence-based in vivo imaging. Luminescence-based readout allowed for early visualisation of the locally overgrown mammary tissue and for longitudinal evaluation of local progression of the tumours. When sampled ex vivo at the age of 10 weeks, all tumours derived from MMTV-Luc2PyVT females displayed robust bioluminescent signal.ConclusionsWe have created a novel transgenic strain for visualisation and longitudinal monitoring of mammary tumour development in transgenic mice as an addition and/or a new and more advanced alternative to manual methods. Generation of this mouse strain is vital for making many of the existing mammary tumour transgenic models applicable for in vivo imaging techniques.
Item Type:
Journal Article

Full metadata record

DC FieldValue Language
dc.contributor.authorZagozdzon, Agnieszka M-
dc.contributor.authorO’Leary, Patrick-
dc.contributor.authorCallanan, John J-
dc.contributor.authorCrown, John-
dc.contributor.authorGallagher, William M-
dc.contributor.authorZagozdzon, Radoslaw-
dc.date.accessioned2012-08-08T15:11:46Z-
dc.date.available2012-08-08T15:11:46Z-
dc.date.issued2012-05-30-
dc.identifier.citationBMC Cancer. 2012 May 30;12(1):209-
dc.identifier.urihttp://dx.doi.org/10.1186/1471-2407-12-209-
dc.identifier.urihttp://hdl.handle.net/10147/237750-
dc.description.abstractAbstractBackgroundNumerous transgenic models have been generated to study breast cancer. However, despite many advantages, traditional transgenic models for breast cancer are also burdened with difficulties in early detection and longitudinal observation of transgene-induced tumours, which in most cases are randomly located and occur at various time points. Methods such as palpation followed by mechanical measurement of the tumours are of limited value in transgenic models. There is a crucial need for making these previously generated models suitable for modern methods of tumour visualisation and monitoring, e.g. by bioluminescence-based techniques. This approach was successfully used in the current study.ResultsA new mouse strain (MMTV-Luc2 mice) expressing Luc2 luciferase primarily in mammary tissue in females, with low-level background expression in internal organs, was generated and bred to homozygosity. After these mice were intercrossed with MMTV-PyVT mice, all double transgenic females developed mammary tumours by the age of 10 weeks, the localisation and progression of which could be effectively monitored using the luminescence-based in vivo imaging. Luminescence-based readout allowed for early visualisation of the locally overgrown mammary tissue and for longitudinal evaluation of local progression of the tumours. When sampled ex vivo at the age of 10 weeks, all tumours derived from MMTV-Luc2PyVT females displayed robust bioluminescent signal.ConclusionsWe have created a novel transgenic strain for visualisation and longitudinal monitoring of mammary tumour development in transgenic mice as an addition and/or a new and more advanced alternative to manual methods. Generation of this mouse strain is vital for making many of the existing mammary tumour transgenic models applicable for in vivo imaging techniques.-
dc.titleGeneration of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice-
dc.typeJournal Article-
dc.language.rfc3066en-
dc.rights.holderAgnieszka M Zagozdzon et al.; licensee BioMed Central Ltd.-
dc.description.statusPeer Reviewed-
dc.date.updated2012-08-03T15:02:04Z-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.